Re-engineered Cold Virus Increases Brain Cancer Patients’ Survival, Phase 1 Trial Shows
Re-engineering a common cold virus to attack the deadliest kind of brain tumor extended the survival of patients whose tumor returned after various treatments, including surgery, a Phase 1 clinical…
